Metastatic Uveal Melanoma Latest Advances

Find the Latest Research About Metastatic Uveal Melanoma

Last Updated: 09/19/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1560 publications

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Key barriers in utilizing advanced T-cell engager strategies on solid tumors.

Journal: Expert review of anticancer therapy
Published: September 07, 2026

Percutaneous Hepatic Perfusion: Continuum of Nursing Care and Safety Implications for Managing Patients With Metastatic Uveal Melanoma.

Percutaneous Hepatic Perfusion: Continuum of Nursing Care and Safety Implications for Managing Patients With Metastatic Uveal Melanoma.

Journal: Clinical journal of oncology nursing
Published: August 05, 2026

Genomic Landscape of GNAQ and GNA11 Mutations in Metastatic Solid Tumors: A Real-World Data Analysis.

Genomic Landscape of GNAQ and GNA11 Mutations in Metastatic Solid Tumors: A Real-World Data Analysis.

Journal: JCO precision oncology
Published: July 06, 2026

Redox Homeostasis, Metabolic Pathways and Plasticity in Uveal Melanoma Compared to Other Cancers.

Redox Homeostasis, Metabolic Pathways and Plasticity in Uveal Melanoma Compared to Other Cancers.

Journal: Cancers
Published: July 03, 2026

Fatty Acid-Binding Protein 5 Potentially Regulates the Proliferation and Metastasis of Uveal Melanoma Cells Through the PI3K/AKT/mTOR Signaling Pathway.

Fatty Acid-Binding Protein 5 Potentially Regulates the Proliferation and Metastasis of Uveal Melanoma Cells Through the PI3K/AKT/mTOR Signaling Pathway.

Journal: CNS neuroscience & therapeutics
Published: June 16, 2026

ImmTAC: A Novel Platform of T-Cell Receptor-Based Soluble Bispecifics.

ImmTAC: A Novel Platform of T-Cell Receptor-Based Soluble Bispecifics.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 10, 2026

Clinicopathological characteristics, diagnostic challenges, and systemic implications of metastatic tumors to the eyelid: a systematic review.

Clinicopathological characteristics, diagnostic challenges, and systemic implications of metastatic tumors to the eyelid: a systematic review.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
Published: May 07, 2026

AI-based tumor and organ volumetry predicts early progression after Y-90 radioembolization in liver-dominant metastatic disease.

AI-based tumor and organ volumetry predicts early progression after Y-90 radioembolization in liver-dominant metastatic disease.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 28, 2026

A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma.

A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma.

Journal: Cancers
Published: April 28, 2026

The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma.

The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma.

Journal: Cancers
Published: April 24, 2026

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report.

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report.

Journal: Frontiers in immunology
Published: April 24, 2026

First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study.

First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case study.

Journal: Journal for immunotherapy of cancer
Published: April 09, 2026
Showing 1-12 of 1,560

Last Updated: 09/19/2026